SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...

The Power Over Prostate and Testicular Cancer Gathering was again held on Nov. 8 at Springhill Missionary Baptist Church in southeast Gainesville.

Metformin does not delay disease progression in men with low risk prostate cancer on active surveillance and is associated ...

His PSA level was 16 ng/mL, higher than the normal limit of 4.0 ng/mL, indicating the presence of tumour. Not only that, it was aggressive, with a high chance of mortality. However, a novel therapy, ...

Men who improve their adherence to ACS guidelines following diagnosis have a reduction in all-cause and cardiovascular mortality compared to those who maintain a low concordance with guideline ...

Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

Cribriform morphology strongly predicts 15-year metastasis in patients with prostate cancer, and radiotherapy with ...

In response to a story that said the Arctic Frost probe of him during the Biden administration was started on dubious grounds, President Trump has apparently called for his predecessor to be ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get ready for your next job interview with a free guide from ...